The onset of the COVID-19 pandemic brought unprecedented disruption to drug development.

John Scannapieco, chair of the Global Business Team at the law firm of Baker Donelson, explains how the U.S.-China trade war, the coronavirus pandemic and global recession are causing companies to rethink the structure of their supply chains.

The coronavirus pandemic has laid bare the inadequacies of many supply chains when it comes to ensuring the safe, secure and rapid delivery of drugs and other critical supplies in a health crisis.

Why do some supply chains bounce back from disruptions more quickly than others? New research from the Association for Supply Chain Management clarifies what makes a company resilient.

What makes a supply chain resilient? A discussion about the findings from a new study by the Council of Supply Chain Management Professionals and the MIT Center for Transportation and Logistics.

Suman Mahalanabis, director of product management for digital software and solutions with Tata Consultancy Services, describes the steps that factories will need to take in order to ensure the health and safety of workers during the pandemic and beyond.

What's the point at which manufacturers decide to shift production from China and return it to the U.S.? Gregory Burkart, managing director and leader of the Site Selection & Incentives Advisory Practice of financial consultancy Duff & Phelps, offers some insight into the calculation.

Spending patterns in the transportation industry are a good barometer of the condition of the economy at large — but the results can be murky.

Peter Canellis, associate professor of management at Vaughn College of Aeronautics and Technology, describes how the teaching of supply-chain management is changing in a time of lockdowns and sheltering-in-place caused by the coronavirus pandemic.

A panel discussion featuring experts from the Dykema law firm and The Right Place about automaker and supplier perspectives on the auto industry and U.S. economy, in the midst of the coronavirus pandemic and beyond.